SK
Sushil Kumar
Immunocombinex Inc, Oregon Health & Science University, Institute of molecular cancer research-UZH, Max Planck Institute of Biochemistry
0000-0002-9882-0722
Employment
-
Immunocombinex Inc CEO2025 - Present
Education
-
Oregon Health & Science University Postdoctoral fellow2012 - 2014
-
Institute of molecular cancer research-UZH Postdoctoral fellow2008 - 2011
-
Max Planck Institute of Biochemistry PhD2003 - 2007
-
Sikkim Manipal University Master of Science2002 - 2004
-
University of Delhi Bachelor of science1997 - 2000
Projects & Funding
Projects & funding information is unavailable.
Publications (19)
- Improving immune checkpoint blockade efficacy using combination therapy with bioactive molecules Save
- Metabolomic and transcriptomic remodeling of bone marrow myeloid cells in response to maternal obesity Save
- Adipose Tissue Dysfunction in the Offspring of Obese Mothers. Save
- Maternal High-Fat Diet Affects Lung Function in the Newly Weaned Offspring. Save
- Metabolic abnormalities in the bone marrow cells of young offspring born to mothers with obesity Save
- Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization Save
- An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences Save
- Metabolic abnormalities in the bone marrow cells of young offspring born to obese mothers Save
- Therapeutics That Promote Sympathetic Reinnervation Modulate the Inflammatory Response After Myocardial Infarction Save
- An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences Save